These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20043321)

  • 21. Implementation of advanced technologies in commercial monoclonal antibody production.
    Zhou JX; Tressel T; Yang X; Seewoester T
    Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
    Nagel A; Koch S; Valley U; Emmrich F; Marx U
    Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the production and downstream processing of antibodies.
    Chon JH; Zarbis-Papastoitsis G
    N Biotechnol; 2011 Sep; 28(5):458-63. PubMed ID: 21515428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposable bioreactors: maturation into pharmaceutical glycoprotein manufacturing.
    Brecht R
    Adv Biochem Eng Biotechnol; 2009; 115():1-31. PubMed ID: 19517075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process.
    Yang JD; Angelillo Y; Chaudhry M; Goldenberg C; Goldenberg DM
    Biotechnol Bioeng; 2000 Jul; 69(1):74-82. PubMed ID: 10820333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioreactor systems for the production of biopharmaceuticals from animal cells.
    Warnock JN; Al-Rubeai M
    Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in antibody manufacturing using mammalian cells.
    Morrow KJ
    Biotechnol Annu Rev; 2007; 13():95-113. PubMed ID: 17875475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.
    Kundu PK; Prasad NS; Datta D
    Indian J Exp Biol; 1998 Feb; 36(2):125-35. PubMed ID: 9754040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systems biotechnology of animal cells: the road to prediction.
    Carinhas N; Oliveira R; Alves PM; Carrondo MJ; Teixeira AP
    Trends Biotechnol; 2012 Jul; 30(7):377-85. PubMed ID: 22541337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of "oxygen uptake rate-amino acids" associated mode in controlled-fed perfusion culture.
    Feng Q; Mi L; Li L; Liu R; Xie L; Tang H; Chen Z
    J Biotechnol; 2006 Apr; 122(4):422-30. PubMed ID: 16274826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting monoclonal antibody production in culture.
    Reuveny S; Velez D; Macmillan JD; Miller L
    Dev Biol Stand; 1987; 66():169-75. PubMed ID: 3582746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Industrialization of mAb production technology: the bioprocessing industry at a crossroads.
    Kelley B
    MAbs; 2009; 1(5):443-52. PubMed ID: 20065641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology.
    Eibl R; Kaiser S; Lombriser R; Eibl D
    Appl Microbiol Biotechnol; 2010 Mar; 86(1):41-9. PubMed ID: 20094714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mining manufacturing data for discovery of high productivity process characteristics.
    Charaniya S; Le H; Rangwala H; Mills K; Johnson K; Karypis G; Hu WS
    J Biotechnol; 2010 Jun; 147(3-4):186-97. PubMed ID: 20416347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Process control in cell culture technology using dielectric spectroscopy.
    Justice C; Brix A; Freimark D; Kraume M; Pfromm P; Eichenmueller B; Czermak P
    Biotechnol Adv; 2011; 29(4):391-401. PubMed ID: 21419837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
    Chiang GG; Sisk WP
    Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in Monoclonal Antibody Production Using Various Bioreactor Syst.
    Jyothilekshmi I; Jayaprakash NS
    J Microbiol Biotechnol; 2021 Mar; 31(3):349-357. PubMed ID: 32238761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.